Participants:0–17 years · Healthy volunteers
Substances:SARS-COV-2 VIRUS, VARIANTS B.1.351-B.1.1.7, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN FUSION HETERODIMER

Contact Research Centre

Breast cancer+2

Not recruiting

Registered drug

Study on Denosumab to Prevent Breast Cancer in Women with BRCA1 Mutation

Registered drug

Spain

Participants:18–64 years · Healthy volunteers
Substances:Denosumab

Contact Research Centre

COVID-19+1

Not recruiting

Registered drug

Study on the Safety of BIMERVAX and Fluad Tetra for COVID-19 and Influenza in Adults Over 65 Who Are Fully Vaccinated Against COVID-19

Registered drug

Spain

Participants:65+ years · Healthy volunteers
Substances:A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227)

Contact Research Centre

Chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Nilotinib

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab, Carboplatin, and Paclitaxel for Patients with Stage I Triple-Negative Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Acasunlimab

Contact Research Centre

Chronic lymphocytic leukaemia+1

Not recruiting

Registered drugNo placebo

Study of Lisaftoclax and Acalabrutinib for Patients with Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Hormone-refractory prostate cancer+2

Not recruiting

Registered drug

Study of Fuzuloparib, Abiraterone Acetate, and Prednisone for First-Line Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Cushing's syndrome

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Pancreatic carcinoma

Not recruiting

Registered drug

Study on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Gemcitabine

Contact Research Centre

Multiple sclerosis

Not recruiting

Investigational

Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Investigational

Spain

Participants:18–64 years
Substances:Frexalimab

Contact Research Centre

Find therapies in clinical trials near you – page 15

295 trials match your criteria

COVID-19

Study on the Safety and Immune Response of PHH-1V81 Booster for Adults Vaccinated Against COVID-19

COVID-19

Study on the Safety and Immune Response of BIMERVAX as a COVID-19 Booster in Adolescents Aged 12 to 17 Years

Breast cancer+2

Study on Denosumab to Prevent Breast Cancer in Women with BRCA1 Mutation

COVID-19+1

Study on the Safety of BIMERVAX and Fluad Tetra for COVID-19 and Influenza in Adults Over 65 Who Are Fully Vaccinated Against COVID-19

Chronic myeloid leukaemia

Study for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib

Triple negative breast cancer

Study of Pembrolizumab, Carboplatin, and Paclitaxel for Patients with Stage I Triple-Negative Breast Cancer

Non-small cell lung cancer metastatic

Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Chronic lymphocytic leukaemia+1

Study of Lisaftoclax and Acalabrutinib for Patients with Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Hormone-refractory prostate cancer+2

Study of Fuzuloparib, Abiraterone Acetate, and Prednisone for First-Line Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer

Cushing's syndrome

Study on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome

Pancreatic carcinoma

Study on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer

Multiple sclerosis

Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.